Septerna Inc

SEPN is in a high-confidence Stage 3 distribution phase, with its higher-high/higher-low structure broken and EMAs turning down. Medium-term bias remains bearish under distribution dynamics, while short-term timing is neutral as price tests lower support. Look to sell into rallies around the 9- and 21-period EMAs for best execution.

• ↑Q1 2026 loss of $0.19/sh bested estimates by 55.3%, stock +8.1%
• ↑Cash runway of $522M via Novo Nordisk collaboration funds operations to 2029
• ↓Ongoing negative profitability and earnings yield indicate poor return generation